Page last updated: 2024-11-01

norfloxacin and Bone Cancer

norfloxacin has been researched along with Bone Cancer in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
"Norfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections."1.39Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures. ( Di Virgilio, AL; Etcheverry, SB; Franca, CA; Henao, I; León, IE; Tobón, G, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Virgilio, AL1
León, IE1
Franca, CA1
Henao, I1
Tobón, G1
Etcheverry, SB1

Other Studies

1 other study available for norfloxacin and Bone Cancer

ArticleYear
Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures.
    Molecular and cellular biochemistry, 2013, Volume: 376, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Coo

2013